ImmunoGen, Inc. (IMGN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ImmunoGen, Inc., with annual and quarterly history.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.64x | -10.98x | -17.04x | -6.21x | -4.00x | -6.55x |
| P/B Ratio | 8.07x | 4.70x | 12.68x | -9.96x | 56.25x | -35.13x |
| P/S Ratio | 11.56x | 21.90x | 8.59x | 9.21x | 12.48x | 5.45x |
| Profitability | ||||||
| Gross Margin | 99.8% | 100.0% | 13.4% | -39.2% | -223.1% | -21.0% |
| Operating Margin | -203.1% | -179.0% | -102.4% | -112.0% | -298.2% | -51.1% |
| Net Margin | -204.9% | -199.4% | -50.4% | -148.4% | -311.9% | -83.2% |
| EBITDA Margin | -198.3% | -177.8% | -14.9% | -79.9% | -285.1% | -48.2% |
| Liquidity | ||||||
| Current Ratio | 2.26x | 4.74x | 2.40x | 2.28x | 3.74x | 4.79x |
| Quick Ratio | 2.50x | 4.95x | 2.65x | 2.70x | 3.98x | 4.77x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.06x | 0.27x | -0.35x | 0.17x | -0.11x |
YoY = year-over-year change. Source: FMP..